Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
GALNS
100%
MPS IVA
100%
Morquio A Disease
100%
Gene Transfer
100%
Virus Gene
100%
Disease Effects
100%
Adenovirus
100%
Sulfatase Modifying Factor 1 (SUMF1)
100%
Promoter Effect
100%
Activity Level
40%
Fibroblasts
40%
Enzyme Activity
40%
Chondrocytes
40%
HEK293 Cells
40%
Lysosomal Enzymes
20%
Gene Therapy
20%
Sulfatase
20%
Complementary DNA (cDNA)
20%
Fold Increase
20%
Autosomal Recessive
20%
Chondroitin-6-sulfate
20%
Keratan Sulfate
20%
Cytomegalovirus
20%
GALNS Gene
20%
Type Selection
20%
Gene Vector
20%
Eukaryotic Promoter
20%
Cytomegalovirus Promoter
20%
Immediate Early
20%
Virus Vector
20%
Normal Fibroblasts
20%
Recombinant Adeno-associated Virus (rAAV)
20%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Mucopolysaccharidosis
100%
Sulfatase
100%
Adeno Associated Virus
100%
Virus Gene
100%
Fibrinogen
100%
Fibroblast
60%
Sulfate
40%
Chondrocyte
40%
Enzyme Activity
40%
Cytomegalovirus
40%
Gene Therapy
20%
Enzyme
20%
Autosomal Recessive Disorder
20%
Normal Human
20%
Downregulation
20%
Chondroitin
20%
Gene Vector
20%
Adeno Associated Virus Vector
20%
Keratan Sulfate
20%
Deficiency
20%
INIS
genes
100%
diseases
100%
viruses
100%
promoters
100%
levels
60%
humans
60%
vectors
60%
sulfates
60%
fibroblasts
60%
enzyme activity
40%
activity levels
40%
applications
20%
enzymes
20%
accumulation
20%
bones
20%
elevation
20%
gene therapy
20%
human cells
20%
chondroitin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Mucopolysaccharidosis
100%
Gene Delivery
100%
Fibrinogen
100%
Sulfatase
100%
Adeno Associated Virus
100%
Diseases
100%
Enzymes
40%
Cytomegalovirus
40%
Autosomal Recessive Disorder
20%
Normal Human
20%
Keratan Sulfate
20%
Lysosome Enzyme
20%
Chondroitin 6 Sulfate
20%
Adeno Associated Virus Vector
20%
Complementary DNA
20%
Sulfate
20%